Abstract Galectins are multifunctional effectors, for example acting as regulators of cell growth via protein-glycan interactions. The observation of capacity to kill bacteria for two tandem-repeat-type galectins, which target histo-blood epitopes toward this end (Stowell et al. Nat. Med. 16:295-301, 2010), prompted us to establish an array with bacterial polysaccharides. We addressed the question whether sugar determinants other than β-galactosides may be docking sites, using human galectins-4, -8, and -9. Positive controls with histoblood group ABH-epitopes and the E. coli 086 polysaccharide ascertained the suitability of the set-up. Significant signal generation, depending on type of galectin and polysacchride, was obtained. Presence of cognate β-galactoside-related epitopes within a polysaccharide chain or its branch will not automatically establish binding properties, and structural constellations lacking galactosides, like rhamnan, were found to be active. These data establish the array as valuable screening tool, giving direction to further functional and structural studies.
Introduction
Epitopes of glycan chains of natural glycoconjugates are increasingly delineated as biochemical signals, their information turned into cellular effects by lectins [1, 2] . In addition to endogenous glycan determinants, tissue lectins, e.g. C-type lectins and galectins, have the ability to target pathogens, as part of defence mechanisms or exploited as sites for bacterial/ viral/yeast attachment [3] [4] [5] [6] . From the family of galectins, which share the β-sandwich fold, a sequence signature and specificity to β-galactosides, special attention has so far been given to galectin-3 with respect to bacterial recognition [4, 7] . The binding of this chimera-type protein (with its tridomain structure constituted by an N-terminal section, collagen-like repeats and the carbohydrate recognition domain (CRD)) involves carbohydrate-dependent/independent mechanisms. Interest in studying galectins was recently further stimulated by the observation that the tandem-repeat-type galectins-4 and -8 (proteins with two CRDs covalently connected by a linker [8] ) can abolish bacterial viability after targeting histo-blood group B antigen on E.coli 086 surface [9] . In fact, the repeating unit of its O-polysaccharide (PS) [10] mimics the B (type 4) antigen. Overall, rather strong interaction with histoblood group epitopes had been reported for the tandem-repeattype galectins-4, -8, and -9 by different methods [9, [11] [12] [13] [14] [15] . Using a cell-based assay, which measures the ligand selection of cell-bound galectins for cross-linking, a clear preference for such epitopes had even been revealed (Fig. 1) [16, 17] .
This preference is phylogenetically conserved, pointing to a physiological role [18] and hereby directing interest to characterizing the range of potential binders among bacterial PSs. The occurrence of such epitopes in PSs of infectious bacteria is very low. Inspection of the relevant public database at http://csdb.glycoscience.ru, which covers about 10,000 structures from around 5,000 organisms, demonstrates that only few of them contain ABH-like motifs, including the polysaccharide from E. coli O86 mentioned above:
and an oligosaccharide from Helicobacter mustelae strain ATCC43772 terminating with the A (type 1) tetrasaccharide:
Since the mode of epitope presentation is known to affect galectin reactivity [19, 20] , the first aim of our study is to figure out whether epitope presence will translate into binding activity. Also, molecular mimicry may endow PSs without β-galactosides, the canonical ligands, with binding capacity, warranting a robust screening. Experimentally, we established an array of PSs from bacteria of the genera Escherichia, Shigella, Salmonella, Cronobacter, Proteus, and Pseudomonas, putting together a total of nearly 150 structurally defined polysaccharides ( Table 1 ). The array also contained a set of nonbacterial glycans as controls, including ABH epitopes [21] .
Material and methods

Reagents
Carbohydrate-free bovine serum albumin (BSA), Na 2 HPO 4 , NaH 2 PO 4 , NaCl and KCl were purchased from Sigma (USA), Tween-20 was from ICN (USA). Alexa-555-labeled streptavidin was obtained from Invitrogen (USA).
Galectins
Recombinant human galectins -4, -8 and -9 were produced using suited vector/bacteria systems as described and then purified from extracts by affinity chromatography on lactosylated Sepharose 4B [22, 23] . Homogeneity was ascertained by gel filtration, also removing any cleaved material such as free CRDs, and by one/two-dimensional gel electrophoreses, biotinylation performed as described in detail previously [24] and carbohydrate-dependent activity tested by solid-phase/cell assays [25, 26] .
Glycans
Polysaccharides were obtained by mild acid degradation (2 % HOAc, 100°C, 1-4 h) of the corresponding lipopolysaccharides isolated from bacterial cells by the Westphal procedure [27] modified as described [28] . The polysaccharides were purified by gel-permeation chromatography on Sephadex G-50 (Superfine) in pyridinium acetate buffer (4 mL pyridine and 10 mL HOAc in 1 L water). Oligosaccharides in form of aminopropyl-, aminoethyl-or glycylamido-glycosides are described in [21] .
Glycan array
Microarrays on glass microscope slides presenting the oligosaccharides and polysaccharides were printed as described 3 A tetra B tetra Fig. 1 Elevated affinity of galectins -4, -8 and -9 towards blood group A and B (types 1 and 2) glycans, data taken from [3] and [4] are shown as partial 'weight' of the corresponding glycan. LN Galβ1-4GlcNAc, Le 
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Galectin-9 Fig. 2 Binding of galectins to bacterial polysaccharides immobilized on microchip compared to trisaccharide H (type 1) and tetrasaccharide B (type 4). Other PSs listed in Table 1 were also assayed, no binding was observed. Background of the assay is considered as~500 RFU [29] . Aliquots of solution of biotinylated galectins (75 μg/ml) in PBS (0.01 М Na 2 HPO 4 , 0.01 M NaH 2 PO 4 , 0.138 M NaCl, and 0.0027 M KCl, pH 7.4) containing 1 % BSA were applied to slides (pretreated with PBS containing 0.1 % Tween-20 for 15 min) and incubated in a humidified chamber at 20°C for 1 h. Therefore, the slides were washed with PBS containing 0.05 % Tween-20 and incubated with a streptavidin-Alexa-555 conjugate (diluted 1:1,000 with PBS containing 0.1 % Tween-20) under the same conditions. After washing with PBS containing 0.05 % Tween-20 and deionized water, slides were scanned on a ProScanArray HT scanner (PerkinElmer, USA) using the excitation wavelength 543 nm. The obtained data were processed using ScanArray Express 3.0 software and the fixed 70 μm-diameter rings method as well as Microsoft Excel. Twelve spots represent each glycan on the array and data are reported as median RFU of replicates. A signal, which fluorescence intensity exceeded the background value by a factor of five, was considered as significant. Controls using nonspacered glycans ensured carbohydrate dependence of binding.
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Results and discussion
A wide panel of PSs was used for probing, among them the one from E. coli 086 as control (Table 1 ) and also synthetic histo-blood ABH-epitopes. Illustrating the highly selective recognition by galectins, only few cases of significant reactivity were detected, and the extent of reactivity between the galectins was found to differ markedly (Fig. 2) . All three galectins bound to α(1-2)-rhamnan from E. coli with the extent exceeding that obtaining for all ABH glycans. Despite shared binding properties to the β-galactoside core owing to the homology the galectins can non-uniformly react with glycan epitopes presented in PSs. Also of note, eight PSs present β-galactosides, which would be expected to be galectin binders, but failed to be reactive; particularly, side β-Gal 1-3-connected to core GalNAc in E. coli 0125, side β-Gal 1-4-connected to core Glc in E. coli 014, inner Galβ1-3(4)Glc(NAc) or Galβ1-3GalNAc in Proteus mirabilis O33 and Proteus mirabilis OE, in Proteus penneri 75, and in Salmonella enterica 013,-in all cases Gal moiety has no "forbidden" for galectin binding substituent at O-4 position. Obviously, the spatial presentation and/or structural context can matter, as also valid in the interpretation of cytoand histochemical results after galectin staining [30, 31] .
Equally important, the compilation of the structures of the repeating units of reactive PSs, given in Table 2 , disclosed binding properties to non-canonical determinants. As to Lrhamnose, a molecular mimicry with D -galactose has been suggested, rendering a recognition process possible [32] ; however, L-Rha monosaccharide in the array (data not shown) was found to be non-binder. Taking into account topological aspects, these studies should not only be performed on free sugars in solution but also on clustered arrangements, which may be required to generate adequate avidity. Methodologically, the array testing has proven to be a convenient way to select candidates for further measuring effects on cell viability when bacteria are exposed to galectins, giving our study model character.
Conclusions
Our results document the ability of array-presented bacterial PSs to detect galectin reactivity. Binding will not automatically occur if a canonical ligand is part of the PS's repeating unit. Obviously, the mode of presentation plays into this process. Intriguingly, reactivity to PSs without presence of a β-galactoside is detected, stimulating interaction analysis of core-unit sugars due to the potential biomedical relevance of this recognition process, in infection as are effector branch of host defense. 
